Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0288-2007

OptiVantage DH Power Injection System

Mallinckrodt, Inc. / initiated 2006-11-07 / Terminated

Mallinckrodt Inc began a recall of OptiVantage DH Power Injection System on . The reason FDA records is "The flow rate programmed on the console may be changed without automatically updating the flow rate programmed on the power head. The injector will always inject in accordance with the parameters shown on the power...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0288-2007
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Mallinckrodt, Inc.
Product
OptiVantage DH Power Injection System.
Product code
CXT
Reason for recall
The flow rate programmed on the console may be changed without automatically updating the flow rate programmed on the power head. The injector will always inject in accordance with the parameters shown on the power head. If this lack of synchronization occurs and is not noticed by the clinican, contrast would be injected at a higher or lower flow rate than desired.
FDA root cause
Other
Action
The recalling firm sent a letter dated 11/7/2006 to all consignees.
Quantity in commerce
1348 devices.
Distribution
Worldwide distribution ---- including USA and countries of Australia, Belgium, Brazil, Canada, Chile, Columbia, Denmark, Mexico, Panama, Puerto Rico, Singapore and South Africa.
Product codes and lots
All codes.